Claritev Corp
CTEV
NYSE
Health Care
$32.59
USD
+5.75 (+21.42%)
At close: Aug 7, 2026, 4:00 PM EDT
Market Cap $445.46M
Volume 330.0K
Revenue
$978.76M
TTM
— YoY
Gross Margin
73%
TTM
— YoY
Net Income
$-286.52M
TTM
— YoY
Operating Cash Flow
$101.60M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 231.3 | 241.6 | 246.0 | 246.6 | 244.7 |
YoY Growth | — | — | — | — | +5.8% |
Cost of Revenue | 60.4 | 60.8 | 62.1 | 70.1 | 69.1 |
Gross Profit | 170.9 | 180.7 | 183.9 | 176.5 | 175.6 |
Selling, General & Administrative | 47.0 | 52.9 | 61.9 | 56.1 | 57.8 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 157.5 | 164.2 | 173.8 | 167.8 | 168.9 |
Operating Income | 13.4 | 16.6 | 10.1 | 8.7 | 6.7 |
EBITDA | 123.9 | 127.8 | 122.0 | 120.4 | 117.8 |
Other Income / Expense | -12.1 | -0.1 | -2.7 | -16.5 | -0.0 |
Total Other Income / Expense | -103.3 | -99.5 | -103.4 | -115.6 | -99.4 |
Income Before Income Taxes | -89.9 | -82.9 | -93.4 | -106.9 | -92.7 |
Income Taxes | -18.5 | -20.3 | -23.6 | -26.3 | -19.2 |
Net Income | -71.3 | -62.6 | -69.8 | -80.6 | -73.6 |
Consolidated Net Income / Loss | -71.3 | -62.6 | -69.8 | -80.6 | -73.6 |
Net Income Attributable to Common Shareholders | -71.3 | -62.6 | -69.8 | -80.6 | -73.6 |
Basic EPS | -$4.38 | -$3.81 | -$4.23 | -$4.88 | -$4.41 |
Diluted EPS | -$4.38 | -$3.81 | -$4.23 | -$4.88 | -$4.41 |
Basic Shares Outstanding | 16.3M | 16.5M | 16.5M | 16.4M | 16.7M |
Diluted Shares Outstanding | 16.3M | 16.5M | 16.5M | 16.4M | 16.7M |